How are governments responding to the COVID-19 pandemic?

Osborne Clarke advises LAVA Therapeutics on $83 million Series C financing

Osborne Clarke advises LAVA Therapeutics on $83 million Series C financing. Osborne Clarke in Amsterdam has advised LAVA Therapeutics, a...

Written on: 17th September 2020


Read time 1m

Osborne Clarke advises Infosys on the acquisition of GuideVision

International legal practice Osborne Clarke has successfully advised Infosys, a global leader in next-generation digital services, on the acquisition of...

Written on: 16th September 2020


Read time 1m

Osborne Clarke advises Terumo on the acquisition of Quirem Medical

Osborne Clarke in Amsterdam has advised Terumo, a global leader in medical technology based in Tokyo, Japan on the acquisition...

Written on: 16th July 2020


Read time 1m

Osborne Clarke assists Currencycloud B.V. with obtaining an electronic money institution license

Osborne Clarke has assisted Currencycloud B.V. with obtaining a license from the Dutch Central Bank to conduct the business of...

Written on: 16th July 2020


Read time 1m

Osborne Clarke in Amsterdam advises iOnctura on extension Series A financing to €20.1M

Osborne Clarke in Amsterdam has advised iOnctura, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting...

Written on: 15th July 2020


Read time 1m

Osborne Clarke in Amsterdam advises ASN Beleggingsinstellingen Beheer B.V. on the split-up of a listed umbrella fund into listed UCITS and AIF umbrella funds

Osborne Clarke in Amsterdam has advised ASN Beleggingsinstellingen Beheer B.V. on the split-up of a listed umbrella fund into listed...

Written on: 14th July 2020


Read time 1m